Investment Summary |
|
|---|---|
| Date | 2019-08-21 |
| Target | Emerging Therapy Solutions |
| Sector | Information Technology |
| Investor(s) | Telegraph Hill Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Venture Capital Firm |
|---|---|
| Founded | 2001 |
| Size | Middle-Market |
| Type | Sector Focused |
Telegraph Hill Partners is a specialist private equity firm focused on investing in later-stage life science, medical device, and healthcare companies. Prospective companies should be at or near profitability and demonstrate success. Other areas of interest within the healthcare sector include life science technologies, chemistry/reagent suppliers, and information management. Telegraph Hill Partners was formed in 2001 and is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 31 of 34 |
| Sector: Information Technology M&A | 2 of 2 |
| Type: Venture M&A Deals | 19 of 20 |
| State: Minnesota M&A | 1 of 1 |
| Country: United States M&A | 28 of 31 |
| Year: 2019 M&A | 4 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-04-30 |
Nimble Therapeutics
Madison, Wisconsin, United States Nimble Therapeutics is a provider of massively parallel chemical synthesis to drug discovery. Nimble’s proprietary technology enables the synthesis and screening of millions of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. Nimble Therapeutics was founded in 2019 and is based in Madison, Wisconsin. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-09-06 |
Specific Diagnostics
San Jose, California, United States Specific Diagnostics is a developer of in vitro diagnostic systems for the detection and identification of microorganisms while they grow in culture. Specific Diagnostics was founded in 2011 and is based in San Jose, California. |
Buy | - |
